XML 19 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Common Stock
Deficit
Accumulated other comprehensive income
Total shareholders' equity
Non-controlling interests
Beginning balance ( in shares) at Dec. 31, 2020   134,311,033        
Beginning balance at Dec. 31, 2020 $ 157,546 $ 549,317 $ (397,812) $ 2,308 $ 153,813 $ 3,733
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (10,910)   (10,908)   (10,908) (2)
Other comprehensive income 353     353 353  
Shares Issued For Cash By At The Market Offering Shares   5,534,166        
Shares Issued For Cash By At The Market Offering 30,603 $ 30,603     30,603  
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 689 689     689  
Share-based compensation 697 $ 697     697  
shares issued for exrcise of stock options (in shares)   278,111        
Shares issued for the vesting of restricted stock units 666 $ 666     666  
Shares issued for the vesting of restricted stock units (in shares)   478,781        
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units (659) $ (659)     (659)  
Shares issued for exercise of warrants (in shares)   190,405        
Shares issued for exercise of warrants 1,105 $ 1,105     1,105  
Shares issued for consulting services (in shares)   (24,000)        
Shares issued for consulting services (95) $ (95)     (95)  
Ending balance (in shares) at Mar. 31, 2021   140,816,496        
Ending balance at Mar. 31, 2021 178,807 $ 581,135 (408,720) 2,661 175,076 3,731
Beginning balance ( in shares) at Dec. 31, 2020   134,311,033        
Beginning balance at Dec. 31, 2020 157,546 $ 549,317 (397,812) 2,308 153,813 3,733
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (21,701)          
Other comprehensive income (544)          
Ending balance (in shares) at Jun. 30, 2021   148,597,701        
Ending balance at Jun. 30, 2021 215,831 $ 629,618 (419,504) 1,764 211,878 3,953
Beginning balance ( in shares) at Mar. 31, 2021   140,816,496        
Beginning balance at Mar. 31, 2021 178,807 $ 581,135 (408,720) 2,661 175,076 3,731
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (10,791)   (10,784)   (10,784) (7)
Other comprehensive income (897)     (897) (897)  
Shares Issued For Cash By At The Market Offering Shares   6,043,937        
Shares Issued For Cash By At The Market Offering 38,040 $ 38,040     38,040  
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 855 855     855  
Share-based compensation 493 $ 493     493  
shares issued for exrcise of stock options (in shares)   251,960        
Shares issued for the vesting of restricted stock units 710 $ 710     710  
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units (48) $ (48)     (48)  
Shares issued for exercise of warrants (in shares)   1,474,439        
Shares issued for exercise of warrants 10,093 $ 10,093     10,093  
Shares issued for consulting services (in shares)   (8,369)        
Shares issued for consulting services $ (50) $ (50)     (50)  
Shares issued for exercise of stock appreciation rights (in shares) 2,500          
Contributions attributable to non-controlling interest           229
Ending balance (in shares) at Jun. 30, 2021   148,597,701        
Ending balance at Jun. 30, 2021 $ 215,831 $ 629,618 (419,504) 1,764 211,878 3,953
Beginning balance ( in shares) at Dec. 31, 2021   156,262,199        
Beginning balance at Dec. 31, 2021 295,526 $ 685,903 (396,271) 1,943 291,575 3,951
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (14,730)   (14,729)   (14,729) (1)
Other comprehensive income 1,766     1,766 1,766  
Shares Issued For Cash By At The Market Offering Shares   413,751        
Shares Issued For Cash By At The Market Offering 4,260 $ 4,260     4,260  
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 96 96     96  
Share-based compensation 862 $ 862     862  
shares issued for exrcise of stock options (in shares)   135,926        
Shares issued for the vesting of restricted stock units 328 $ 328     328  
Shares issued for the vesting of restricted stock units (in shares)   362,350        
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units (884) $ (884)     (884)  
Shares issued for consulting services (in shares)   (6,022)        
Shares issued for consulting services (51) $ (51)     (51)  
Ending balance (in shares) at Mar. 31, 2022   157,180,248        
Ending balance at Mar. 31, 2022 287,083 $ 690,424 (411,000) 3,709 283,133 3,950
Beginning balance ( in shares) at Dec. 31, 2021   156,262,199        
Beginning balance at Dec. 31, 2021 295,526 $ 685,903 (396,271) 1,943 291,575 3,951
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (32,789)          
Other comprehensive income (1,722)          
Ending balance (in shares) at Jun. 30, 2022   157,569,420        
Ending balance at Jun. 30, 2022 270,516 $ 695,404 (429,054) 221 266,571 3,945
Beginning balance ( in shares) at Mar. 31, 2022   157,180,248        
Beginning balance at Mar. 31, 2022 287,083 $ 690,424 (411,000) 3,709 283,133 3,950
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (18,059)   (18,054)   (18,054) (5)
Other comprehensive income (3,488)     (3,488) (3,488)  
Shares Issued For Cash By At The Market Offering Shares   356,028        
Shares Issued For Cash By At The Market Offering 3,808 $ 3,808     3,808  
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 86 86     86  
Share-based compensation 1,147 $ 1,147     1,147  
shares issued for exrcise of stock options (in shares)   24,326        
Shares issued for the vesting of restricted stock units 67 $ 67     67  
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units (11) $ (11)     (11)  
Shares issued for consulting services (in shares)   (5,183)        
Shares issued for consulting services $ (55) $ (55)     (55)  
Shares issued for exercise of stock appreciation rights (in shares) 3,635          
Ending balance (in shares) at Jun. 30, 2022   157,569,420        
Ending balance at Jun. 30, 2022 $ 270,516 $ 695,404 $ (429,054) $ 221 $ 266,571 $ 3,945